logo
Select company
Select metric
$ -9.25MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
26
Sector
62
Industry
24
History
88
$ 5.08Close
$ 2.82 - $ 16.95 52-Week Range
Ticker Information

Ticker

EKSO

Company Name

EKSO BIONICS HOLDINGS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

EKSO BIONICS HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EKSO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.56M$ -10.81M$ -9.25M
3/31/2025$ 1.58M$ -10.51M$ -8.93M
12/31/2024$ 1.61M$ -11.06M$ -9.45M
9/30/2024$ 1.89M$ -10.86M$ -8.97M
6/30/2024$ 1.82M$ -12.16M$ -10.34M
3/31/2024$ 1.69M$ -13.99M$ -12.3M
12/31/2023$ 1.7M$ -14.9M$ -13.2M
9/30/2023$ 1.28M$ -14.84M$ -13.57M
6/30/2023$ 1.11M$ -15.81M$ -14.71M
3/31/2023$ 1.17M$ -14.59M$ -13.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EKSO BIONICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -13.75M.
  • Over the past 5 years, EKSO BIONICS HOLDINGS INC's average EBITDA has been $ -11.69M.
  • The median EBITDA for EKSO BIONICS HOLDINGS INC during this period was $ -11.93M
  • EKSO BIONICS HOLDINGS INC reached its highest EBITDA over the past 5 years at $ -5.79M.
  • The lowest EBITDA recorded by EKSO BIONICS HOLDINGS INC in the same timeframe $ -16.27M

EKSO BIONICS HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CARM : CARISMA THERAPEUTICS INC $ -45.68MVSEE : VSEE HEALTH INC $ -57.75MLUCY : INNOVATIVE EYEWEAR INC $ -7.58MCSCIF : COSCIENS BIOPHARMA INC $ -16.25MEVOK : EVOKE PHARMA INC $ -4.83MNXGL : NEXGEL INC $ -2.29MPOAI : PREDICTIVE ONCOLOGY INC $ -9.07MBNGO : BIONANO GENOMICS INC $ -60.9MSNOA : SONOMA PHARMACEUTICALS INC $ -3.02MMSPR : MSP RECOVERY INC $ -117.28M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for EKSO BIONICS HOLDINGS INC is calculated as follows: EBIT [ $ -14.39M ] + DepAmor [ $ 636K ]
(=) EBITDA [ $ -13.75M ]

EKSO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -16.27M

Minimum

Mar 31, 2021

$ -5.79M

Maximum

Jun 30, 2021

$ -11.69M

Average

$ -11.93M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M